Health
New gel could be used as nasal spray for treating Parkinson’s patients – News-Medical.Net
Scientists at the University of York have made significant progress in the development of a nasal spray treatment for patients with Parkinson’s disease.
Scientists at the University of York have made significant progress in the development of a nasal spray treatment for patients with Parkinson’s disease.
Researchers have developed a new gel that can adhere to tissue inside the nose alongside the drug levodopa, helping deliver treatment directly to the brain.
Levodopa is converted to dopamine in the brain, which makes-up for the deficit of dopamine-producing cells in Parkinson’s patients, and helps treat the symptoms of the disease. Over extended…
-
Business17 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025
-
General5 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
General23 hours agoPope Leo XIV urges Hollywood actors to resist algorithms and save neighbourhood cinemas
-
Business21 hours agoNvidia’s quiet move into quantum computing could reshape the next frontier of AI